Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionEnvestnet Asset Management Inc
Latest Disclosed Ownership218,710 shares
Latest Disclosed Value $ 28,812,867
Envestnet Asset Management Inc reports 5.79% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 4, 2026 - Envestnet Asset Management Inc filed a 13F-HR form disclosing ownership of 218,710 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $28,812,867 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 206,731 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 5.79% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 218,710 11,979 5.79 28,813 -1.73 0.0077
2026-02-10 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 206,731 3,885 1.92 29,321 2.97 0.0087
2025-11-05 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 202,846 4,807 2.43 28,476 14.40 0.0082
2025-08-01 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 198,039 75,733 61.92 24,891 84.01 0.0073
2025-04-29 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 122,306 -80,904 -39.81 13,527 -51.23 0.0044
2025-02-13 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 203,210 -30,330 -12.99 27,738 3.08 0.0089
2024-11-07 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 233,540 30,747 15.16 26,908 -3.62 0.0087
2024-08-08 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 202,793 3,396 1.70 27,919 1.52 0.0097
2024-05-13 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 199,397 -189 -0.09 27,501 4.57 0.0103
2024-02-13 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 199,586 6,742 3.50 26,297 21.22 0.0109
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 192,844 110,624 134.55 21,695 179.81 0.0099
2023-08-04 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 82,220 -324,562 -79.79 7,753 -35.16 0.0034
2023-05-11 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 406,782 283,315 229.47 11,957 -18.91 0.0057
2023-02-07 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 123,467 -856 -0.69 14,747 11.68 0.0076
2022-11-10 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 124,323 -1,903 -1.51 13,204 7.31 0.0075
2022-08-03 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 126,226 5,784 4.80 12,305 8.98 0.0069
2022-05-04 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 120,442 35,452 41.71 11,291 55.97 0.0057
2022-02-04 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 84,990 -13,160 -13.41 7,239 -23.10 0.0036
2021-10-07 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 98,150 7,127 7.83 9,414 6.28 0.0052
2021-08-04 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 91,023 2,474 2.79 8,858 2.87 0.0050
2021-05-04 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 88,549 8,621 10.79 8,611 12.40 0.0056
2021-02-02 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 79,928 374 0.47 7,661 0.14 0.0058
2020-10-09 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 79,554 32,384 68.65 7,650 32.93 0.0068
2020-07-08 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 47,170 3,728 8.58 5,755 53.06 0.0056
2020-04-23 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 43,442 7,286 20.15 3,760 -3.24 0.0045
2020-02-11 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 36,156 1,010 2.87 3,886 22.70 0.0041
2019-10-17 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 35,146 4,027 12.94 3,167 20.56 0.0035
2019-08-02 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 31,119 2,829 10.00 2,627 5.42 0.0033
2019-05-10 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,290 8,287 41.43 2,492 74.51 0.0034
2019-02-12 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 20,003 20,003 1,428 0.0022
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -497 -100.00 0 -100.00
2018-08-10 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 497 92 22.72 49 44.12 0.0001
2018-05-09 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 405 53 15.06 34 25.93 0.0001
2018-02-20 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 352 -25 -6.63 27 17.39 0.0001
2017-11-13 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 377 -386 -50.59 23 -34.29 0.0001
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 763 -80 -9.49 35 -2.78 0.0001
2017-05-09 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 843 142 20.26 36 33.33 0.0001
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 701 -340 -32.66 27 -49.06 0.0001
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,041 1,041 0.00 53 0.0002
2016-05-16 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -1,260 -100.00 0 -100.00
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,260 -152 -10.76 71 26.79 0.0003
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,412 1,412 0.00 56 0.0003
2015-02-12 2014-12-31 13F Neurocrine Biosciences COM 64125C109 0 -35 -100.00 0 -100.00
2014-11-13 2014-09-30 13F Neurocrine Biosciences COM 64125C109 35 0 0.00 1 0.00 0.0000
2014-08-14 2014-06-30 13F * NEUROCRINE BIOSCIENCES COM 64125C109 35 0 0.00 1 0.00 0.0000
2014-05-12 2014-03-31 13F Neurocrine Biosciences COM 64125C109 35 35 1 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.